Truist Securities Downgrades MEI Pharma (MEIP) to Hold as Lead Drug Discontinued Ex-Japna
Tweet Send to a Friend
(Updated - December 6, 2022 8:58 AM EST)
Truist Securities analyst Robyn Karnauskas downgraded MEI Pharma (NASDAQ: MEIP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Robyn Karnauskas downgraded MEI Pharma (NASDAQ: MEIP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
